Drugs / Spinosad

Regulatory milestones approvals, filings & regulatory actions · 4 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Filed Other Natroba™ head lice, scabies 2026-01-28

“Health Canada has accepted for review Cipher’s new drug submission (“ NDS ”) for Natroba™ (Spinosad), for the treatment of head lice and scabies.” cipherpharma.com ↗

Label expansions (2) US (FDA) NATROBA — 2014-12-30 – 2021-04-28 fda.gov ↗
Approved US (FDA) NATROBA — 2011-01-18 fda.gov ↗

Trials 11

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT00605956 Jan → Feb 2008 Pediculus humanus capitis infestation ParaPRO LLC Completed No outcome recorded
Phase 1 NCT00591331 Dec 2007 Pediculus humanus capitis infestation ParaPRO LLC Completed No outcome recorded
Phase 1 NCT00410709 Dec 2006 → Jan 2007 Pediculus humanus capitis infestation ParaPRO LLC Completed No outcome recorded
Phase 22 trials
Phase 2 NCT00988494 Sep 2009 → ? corneal disorder Santen Pharmaceutical Co., Ltd. Completed No outcome recorded
Phase 2 NCT00311779 Mar → Jul 2006 Pediculus humanus capitis infestation ParaPRO LLC Completed No outcome recorded
Phase 34 trials
Phase 3 NCT02485704 May 2017 → Aug 2018 scabies ParaPRO LLC Completed No outcome recorded
Phase 3 NCT02485717 May 2017 → Jun 2018 scabies ParaPRO LLC Completed No outcome recorded
Phase 3 NCT00545753 Sep 2007 → Mar 2008 lice infestation ParaPRO LLC Completed No outcome recorded
Phase 3 NCT00545168 Sep 2007 → Mar 2008 Pediculus humanus capitis infestation ParaPRO LLC Completed No outcome recorded
Phase 42 trials
Phase 4 NCT05310734 Mar 2022 → Nov 2025 scabies Cipher Pharmaceuticals Inc. Unknown No outcome recorded
Phase 4 NCT01660321 Sep → Oct 2011 lice infestation ParaPRO LLC Completed No outcome recorded
Comparator or background therapy2 trials
Phase 2 NCT06720896 Comparator Nov 2025 → Jun 2026 overdue blepharitis Aperta Biosciences, LLC Active not recruiting No outcome recorded
Phase 2 NCT00858481 Comparator Sep → Nov 2005 Pediculus humanus capitis infestation ParaPRO LLC Completed No outcome recorded

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2026-01-28 Cipher Pharmaceuticals Inc. Regulatory Cipher Pharmaceuticals Announces Health Canada’s Acceptance for Review of New Drug Submission for Natroba™ (Spinosad) cipherpharma.com ↗
today announced that Health Canada has accepted for review Cipher’s new drug submission (“ NDS ”) for Natroba™ (Spinosad), for the treatment of head lice and scabies.

Evidence & citations 25 cited values

Every value below carries the sentence it was read from. 14 sources stand behind the page.

FieldValueCited text
Known as Spinosad “Spinosad (the active ingredient in NatrOVA) and its formulations have been approved as agricultural insecticides in the US, Canada and Australia, and has received provisional...” NCT00410709 ↗
11

“NatrOVA Creme Rinse - 1% spinosad” NCT00605956 ↗

NCT00311779 ↗

NCT02485704 ↗

NCT00858481 ↗

NCT00545753 ↗

NCT00591331 ↗

NCT00545168 ↗

NCT01660321 ↗

NCT02485717 ↗

NCT05310734 ↗

Show 1 more source

Known as APT-001 “APT-001 topical ophthalmic ointment (spinosad)” NCT06720896 ↗
Known as Blackhawk ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Comfortis ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Conserve ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as DE-105 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00988494 ↗
Known as Entrust ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Extinosad ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Justice ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as LY-232105 ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Natroba “Natroba (spinosad) topical suspension versus placebo” NCT02485717 ↗
1

“Natroba” NCT05310734 ↗

Known as Natroba (spinosad) “Natroba (spinosad)” NCT02485704 ↗
Known as Natroba (spinosad) Topical Suspension, 0.9% “Natroba (spinosad) Topical Suspension, 0.9%” NCT02485717 ↗
4

“Natroba (spinosad) Topical Suspension, 0.9%” NCT01660321 ↗

“Natroba (spinosad) Topical Suspension, 0.9%” NCT00545168 ↗

“Natroba (spinosad) Topical Suspension, 0.9%” NCT02485704 ↗

“Natroba (spinosad) Topical Suspension, 0.9%” NCT00545753 ↗

Known as Natrova ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Naturalyte ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as PP-105 ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Spinosad (ema epar: veterinary) ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Spinosad component of trifexis ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Spinosyns spinosad ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Spintor ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Success ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as Tracer ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Known as XDE-105 ChEMBL registry synonym — accepted as the source's own label CHEMBL4297065 ↗
Modality Small molecule — CHEMBL4297065 ↗
Route Topical “Spinosad topical creme” NCT00311779 ↗